To evaluate the Anesthetic efficacy of 0.75%, 0.50% and 0.20% ropivacaine without vasoconstrictor in the minor and major Oral and Maxillofacial Surgical procedures
Lahiri, J., Garg, D., Rai, A. (2024). To evaluate the Anesthetic efficacy of 0.75%, 0.50% and 0.20% ropivacaine without vasoconstrictor in the minor and major Oral and Maxillofacial Surgical procedures. EKB Journal Management System, 15(3), 102-106. doi: 10.21608/OMX.2024.275373.1230
Jagriti Lahiri; Dev Garg; A. Rai. "To evaluate the Anesthetic efficacy of 0.75%, 0.50% and 0.20% ropivacaine without vasoconstrictor in the minor and major Oral and Maxillofacial Surgical procedures". EKB Journal Management System, 15, 3, 2024, 102-106. doi: 10.21608/OMX.2024.275373.1230
Lahiri, J., Garg, D., Rai, A. (2024). 'To evaluate the Anesthetic efficacy of 0.75%, 0.50% and 0.20% ropivacaine without vasoconstrictor in the minor and major Oral and Maxillofacial Surgical procedures', EKB Journal Management System, 15(3), pp. 102-106. doi: 10.21608/OMX.2024.275373.1230
Lahiri, J., Garg, D., Rai, A. To evaluate the Anesthetic efficacy of 0.75%, 0.50% and 0.20% ropivacaine without vasoconstrictor in the minor and major Oral and Maxillofacial Surgical procedures. EKB Journal Management System, 2024; 15(3): 102-106. doi: 10.21608/OMX.2024.275373.1230

To evaluate the Anesthetic efficacy of 0.75%, 0.50% and 0.20% ropivacaine without vasoconstrictor in the minor and major Oral and Maxillofacial Surgical procedures

Egyptian Journal of Oral and Maxillofacial Surgery
Volume 15, Issue 3, July 2024, Page 102-106  XML PDF (371.75 K)
Document Type: Original Article
DOI: 10.21608/OMX.2024.275373.1230
View on SCiNiTO View on SCiNiTO
Authors
Jagriti Lahiri email orcid 1; Dev Garg2; A. Rai2
1Department Of Oral and Maxillofacial Surgery, Maitri College of Dentistry And Research Centre, Anjora ,Durg
2Department of Oral & Maxillofacial surgery , Pacific Dental College and Hospital, Debari , Udaipur (Rajasthan)
Abstract
Objective: This study aims to evaluate the onset, duration, and quality of anesthesia, along with the duration of analgesia, in
seventy-five randomly selected patients undergoing oral and maxillofacial surgery.
Methods: Patients were divided into three groups receiving local anesthesia with intraoral Ropivacaine. Onset of anesthesia
was assessed verbally, and depth was measured using an electric pulp tester. Anesthesia quality was rated on a 7-point scale,
and duration was determined by pain perception lapse.
Results: Onset durations for subjective symptoms were 0.75% (1.240.52± minutes), 0.50% (1.801± minute), and 0.20%
(2.680.90± minutes). Objective symptom onsets were 0.75% (2.660.65± minutes), 0.50% (3.91.32± minutes), and 0.20%
(6.841.26± minutes), with faster onset at 0.75%. Mean anesthesia duration was longest for 0.75% (8.021.11± hrs), and analgesia
duration was also longest for 0.75% (4.493.29± hrs). Nine patients in 0.75% and eight in 0.50% reported no post-procedure
pain, while all in 0.20% experienced pain. Anesthesia duration significantly differed (p=0.001), but analgesia duration did not
(p=0.09).
Conclusion: This study demonstrates that anesthesia onset is faster and duration is longer with higher concentrations of
Ropivacaine. While anesthesia duration significantly varied among concentrations, analgesia duration did not show significant
differences.
Keywords
Onset of Anesthesia; Quality of Anesthesia; Ropivacaine; Different concentrations; Pain perception
Statistics
Article View: 157
PDF Download: 125